Antibiotice S.A. (BVB:ATB)
2.435
+0.115 (4.96%)
At close: Jun 6, 2025
Antibiotice Revenue
Antibiotice had revenue of 163.87M RON in the quarter ending March 31, 2025, a decrease of -11.89%. This brings the company's revenue in the last twelve months to 666.58M, up 7.70% year-over-year. In the year 2024, Antibiotice had annual revenue of 688.70M with 11.93% growth.
Revenue (ttm)
666.58M
Revenue Growth
+7.70%
P/S Ratio
2.45
Revenue / Employee
491.58K
Employees
1,357
Market Cap
1.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 688.70M | 73.41M | 11.93% |
Dec 31, 2023 | 615.29M | 110.29M | 21.84% |
Dec 31, 2022 | 505.00M | 126.17M | 33.31% |
Dec 31, 2021 | 378.83M | 31.60M | 9.10% |
Dec 31, 2020 | 347.22M | -47.92M | -12.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
S.P.E.E.H. Hidroelectrica | 8.52B |
OMV Petrom | 34.60B |
Banca Transilvania | 9.68B |
SNGN Romgaz | 8.04B |
BRD - Groupe Société Générale | 3.93B |
S.N. Nuclearelectrica | 5.14B |
Digi Communications | 12.14B |
S.N.T.G.N. Transgaz | 4.63B |